Le Lézard
Classified in: Ebola virus, Health
Subject: PDT

Clorox Healthcare Canada sets sights on helping to reduce hospital-borne infections and improve patient outcomes


TORONTO, Feb. 28, 2018 /CNW/ - Clorox Healthcare Canada's innovative array of disinfecting solutions are helping healthcare professionals in leading the fight against emerging hospital-borne infections, safeguarding patients in the places where they're most vulnerable.

Aging demographics and a spike in chronic conditions amongst Canadians combined with increased turnover of hospital rooms has forced healthcare providers to re-think their strategies for protecting patients at their most critical moments.

The threat is real. More than 200,000 patients get infections every year while receiving healthcare in Canada and more than 8,000 of these patients die as a result, according to a 2013 report from Canada's chief public health officer1.

To protect patients, hospitals have had to bolster their infection control teams and collaboration between infection prevention and environmental services as well as critical staff.

"There's been a greater effort to detect these bugs," explains Barley Chironda MSc, RPN, CIC Healthcare National Sales Director and Infection Control Specialist at Clorox Healthcare Canada. "What hospitals have realized is when there's a strong relationship between the infection prevention control and environmental services teams, then you actually have better compliance and reduced infection rates ? so that collaboration between those two stakeholders is significant."

To keep pace with the healthcare industry's evolving needs, Clorox Healthcare Canada has bolstered its own research surrounding microbiology, sporicidal agents and infection prevention. The result is a stream of innovative new products specifically for the hospital environment including Clorox Healthcare® Hydrogen Peroxide Cleaner Disinfectant Wipes, Clorox Healthcare® Bleach Germidical Wipes and Clorox Healthcare® Fusiontm Cleaner Disinfectant, a next-generation bleach product combining disinfecting efficacy against pathogens with broad surface compatibility.

The suite of ready-to-use facility-wide disinfectants for healthcare professionals tackle emerging pathogens like Clostridium difficile (C. difficile) spores, a bacterium causing serious illness in Canadian hospitals.

"One of the reasons C. difficile spreads so much is it creates that hard spore shell, making it extremely challenging to kill," says Chironda. "What we've been able to do at Clorox Healthcare is combine the technology of the bleach in the form of a wipe, making it a simple and efficient cleaning process."

Clorox Healthcare Canada offers a robust portfolio of surface cleaner-disinfectants, in addition to UV technology, to provide healthcare facilities with a comprehensive approach to environmental hygiene in efforts to prevent hospital-borne infections. Long trusted as a leader in disinfectant efficacy, Clorox Healthcare Canada also understands the challenges facilities face in balancing the need to prevent infections while protecting surfaces and costly equipment from damage.

Where sensitive surfaces require non-bleach solutions, Clorox Healthcaretm Hydrogen Peroxide Cleaner Disinfectant Wipes is a bleach alternative that kills 38 pathogens in one minute or less. The Clorox Healthcaretm Professional Disinfecting Bleach Wipes wipes provide broad-spectrum antimicrobial efficacy, able to combat 46 pathogens with kill times of one minute and effective against C. difficile spores in three minutes.

"C. difficile is the most critical pathogen facing healthcare, tomorrow it could be Ebola, the day after that it could be SARS, over the last couple of years we've had so many emerging threats," says Chironda. "For years Clorox Healthcare Canada has led the field with disinfectants that healthcare facilities trust for their broad efficacy, fast kill times and ease of use. So when emerging pathogens come through the doors, hospitals are even more prepared."

Visit www.cloroxprofessional.ca for more information.

_________________

1 https://www.canada.ca/en/public-health/corporate/publications/chief-public-health-officer-reports-state-public-health-canada/chief-public-health-officer-report-on-state-public-health-canada-2013-infectious-disease-never-ending-threat/healthcare-associated-infections-due-diligence.html (Accessed August 13, 2017)

 

SOURCE Clorox Healthcare Canada


These press releases may also interest you

at 08:03
For many migraine sufferers, the onset of a migraine headache can be unexpected, severe and debilitating. While some migraine episodes can be minor, others leave people incapacitated and unable to work or perform daily activities. What's more, those...

15 jan 2019
This report analyzes the worldwide markets for Medical Thermometers in US$ Thousand.Read the full report: https://www.reportlinker.com/p05721218 The Global market is further analyzed by the following Product Segments: Digital Thermometers, Infrared...

15 jan 2019
Inovio Pharmaceuticals, Inc. announced today the successful development of optimized DNA-encoded monoclonal antibodies (dMAbstm) targeting the immune checkpoint molecule PD-1. The breakthrough preclinical data demonstrated that a single injection of...

14 jan 2019
Mission Aviation Fellowship (MAF) has been transporting vaccines, medical personnel and supplies, and sanitation equipment into the North Kivu province of the Democratic Republic of the Congo (DRC) since early August to aid efforts to stem an...

14 jan 2019
International humanitarian organizations Lutheran World Relief and IMA World Health today announced they are combining operations to dramatically increase their impact on breaking the cycle of poverty and promoting healthier families and communities...

11 jan 2019
The "Diaper Market by Age - Global Market Size, Share, Development, Growth, and Demand Forecast, 2013-2023" report has been added to ResearchAndMarkets.com's offering. Global diaper market is projected to reach $84,317.6 million by 2023, increasing...



News published on 28 february 2018 at 06:00 and distributed by: